PubMed:27374087 / 257-405 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T30","span":{"begin":11,"end":15},"obj":"PR:Q9V853"},{"id":"T32","span":{"begin":62,"end":66},"obj":"CVCL_5552"},{"id":"T31","span":{"begin":62,"end":66},"obj":"D002285"},{"id":"T33","span":{"begin":62,"end":66},"obj":"D002285"},{"id":"T34","span":{"begin":86,"end":96},"obj":"D012008"},{"id":"T35","span":{"begin":86,"end":96},"obj":"D012008"},{"id":"T36","span":{"begin":140,"end":147},"obj":"D009369"},{"id":"T37","span":{"begin":140,"end":147},"obj":"D009369"}],"text":"Due to the lack of molecularly targeted therapies, basal-like DCIS has a high risk of recurrence and progression to invasive and metastatic cancers."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T2","span":{"begin":0,"end":148},"obj":"DRI_Background"}],"text":"Due to the lack of molecularly targeted therapies, basal-like DCIS has a high risk of recurrence and progression to invasive and metastatic cancers."}